The work in the pharmaceuticals touches on global health issues. I've worked in pharma in sub-Saharan Africa, and I'm still involved with my former Pfizer colleagues in some malaria programs. The work with pharma doesn't mean that the global health perspective that I had in the initial stages of my career has disappeared. I was involved in setting up a chronic disease management in respiratory medicine in Africa. I collaborated with U.K. physicians and with African physicians. I believe I have maintained my original perspective. It has been strongly enriched by methodological learnings that I've acquired through the years. They are fundamental to the development of new technologies. You cannot develop technologies without looking at methodologies, and these methodologies will inform the work that we mean to establish with the academic communities.
I take your point, but I believe that I have been able to maintain, through my activities and across therapeutic areas, a strong focus on health.